The ice cream industry, facing declining sales from weight-loss drugs and wellness trends, is innovating with 'functional' and 'hyper-processed' treats. This article explores the shift towards health-marketed ice creams, expert criticisms of their true value, and the enduring appeal of traditional, pleasure-focused parlors.
The article details a visit to Britain's largest ice cream factory and Magnum's innovation hub, revealing how the industry is adapting to significant challenges. Falling sales, partly attributed to the widespread use of weight-loss drugs (GLP-1s) and a growing consumer emphasis on health, protein, and label-reading, are pushing manufacturers to develop new 'functional' ice creams. These include vitamin-enriched options like Hydro:Ice, protein-packed Yasso, and smaller 'Bonbon' portions, marketed as 'food as medicine' or for 'controlled pleasure.' However, food experts like Professor Chris van Tulleken and scientist Barry Smith are highly critical, explaining that most commercial ice creams are ultra-processed and that added vitamins are often marketing ploys. They warn that 'diet' versions frequently contain more artificial chemicals like sweeteners and maltodextrin, which can disrupt gut health and satiety signals, potentially undermining health goals. This trend is described as 'hyper-processing' designed to bypass the effects of weight-loss drugs and changing appetites. In stark contrast, the author finds optimism in traditional, independent ice cream parlors like Morelli's Gelato, which continue to thrive by offering fresh, additive-free, indulgent treats. These establishments, less impacted by health fads, highlight the enduring human desire for ice cream as a simple, joyful pleasure, suggesting that despite the industry's pivot to 'functional' foods, the frivolous allure of ice cream may ultimately persist.
